Results 111 to 120 of about 13,569 (208)

Antiagregantes plaquetarios: mecanismos de acción y riesgos asociados al uso Platelet antiaggregants: mechanisms of action and use asocied risks

Vitae, 2009
Las Enfermedades Cardiovasculares son la principal causa de muerte en el mundo. Junto con los esfuerzos en disminuir los factores de riesgo cardiovascular, se recurre a diversos medicamentos para disminuir la morbimortalidad asociada a estas enfermedades,
Iván F PALOMO G, Constanza I TORRES U, Rodrigo E MOORE-CARRASCO, Marcelo A ALARCÓN L, Patricio J MARAGAÑO L   +4 more
doaj  

Importance of Complex Additional Stenosis After Primary Angioplasty for Acute Myocardial Infarction in Medium-Term Prognosis [PDF]

, 2004
Introdução: Existe alguma controvérsia respeitante ao tipo de revascularização a efectuar no contexto de angioplastia (PCI) primária no enfarte agudo do miocárdio (EAM).
Cruz Ferreira, R, Feliciano, J, Ferreira, ML, Fiarresga, A, Gonçalves, JM, Quininha, J, Timóteo, AT   +6 more
core  

1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention.

Journal of the American College of Cardiology, 2016
R. Piccolo, I. Eitel, G. Galasso, A. Domínguez-Rodríguez, A. Iversen, P. Abreu-González, S. Windecker, H. Thiele, F. Piscione   +8 more
semanticscholar   +1 more source

PLATELET ANTIAGGREGANTS: MECHANISMS OF ACTION AND USE ASOCIED RISKS

Vitae, 2009
Cardiovascular diseases are the main cause of death in the world. Next to efforts to reduce the cardiovascular risk factors, several drugs are resorted to decrease morbimortality associated to these diseases: antihypertensive, antidiabetic, hypolipemiant
Iván F. PALOMO G, Constanza I. TORRES U., Rodrigo E. MOORE-Carrasco., Marcelo A. ALARCÓN L., Patricio J. MARAGAÑO L.   +4 more
doaj  

Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy.

Journal of the American College of Cardiology, 2012
Dirk Sibbing, I. Bernlochner, S. Schulz, Steffen Massberg, A. Schömig, J. Mehilli, A. Kastrati   +6 more
semanticscholar   +1 more source

Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial.

Journal of the American Medical Association (JAMA), 2012
G. Stone, A. Maehara, B. Witzenbichler, J. Godlewski, H. Parise, J. Dambrink, A. Ochała, Trevor W Carlton, E. Cristea, S. Wolff, S. Brener, S. Chowdhary, M. El-omar, T. Neunteufl, D. Metzger, T. Karwoski, J. Dizon, R. Mehran, C. Gibson   +18 more
semanticscholar   +1 more source

Los inhibidores de los receptores plaquetarios IIb/IIIa en los síndromes coronarios agudos.

Revista Cubana de Cardiología y Cirugía Cardiovascular, 2012
Los inhibidores de los receptores IIb/IIIa, un nuevo grupo de antiagregantes plaquetarios, son potentes bloqueadores del receptor que media la agregación plaquetaria y de ese modo bloquean la vía final común de la formación del trombo plaquetario.
Fidel Manuel Cáceres Lóriga, Horacio Pérez López   +1 more
doaj  

Safety of Abciximab injection during endovascular treatment of ruptured aneurysms

Interventional Neuroradiology, 2015
J. Gentric, Joelle Brisson, A. Batista, J. Ghostine, J. Raymond, D. Roy, A. Weill   +6 more
semanticscholar   +1 more source

Intracoronary adjunctive therapies for ST-elevation myocardial infarction: a network meta-analysis of trials. [PDF]

Eur Heart J Cardiovasc Pharmacother
Laborante R, Bianchini E, Ciliberti G, Paglianiti DA, Filomia S, Bianchini F, Galli M, Biondi-Zoccai G, Serruys PW, Crea F, Patti G, Savarese G, Trani C, Burzotta F, D'Amario D.   +14 more
europepmc   +1 more source

Thrombo-inflammation and Rethinking the Role of Aspirin in Kawasaki Disease. [PDF]

Curr Rheumatol Rep
Kocatürk B, Berberoğulları B, Aliyev E, Sağ E, Özen S, Arditi M.   +5 more
europepmc   +1 more source